CHRISTIAN SHAW PhD MD

NEW CBD RESEARCH - THE OPIOID CRISIS

CHRISTIAN SHAW, PhD, MD

  • Board Certification in Public Health and General Preventative Medicine
  • Subspecialty Board Certification in Addiction Medicine
  • Certification in Integrative Medicine
    PhD in Neurological Sciences

 

Christian Shaw is a physician and neuroscientist specializing in the clinical practice of addiction, occupational and preventive medicine. His multinational medical and scientific training has provided him exposure to health systems around the globe, including Canada, England, and South Africa. He is certified by the American Board of Preventive Medicine in Public Health and General Preventive Medicine and subspecialty board certified in Addiction Medicine. Dr. Shaw serves as the consulting medical director for drug and alcohol treatment centers in Arizona, New Mexico, and Indiana, as well as a corporate physician consultant within the energy industry.

Dr. Shaw initially became interested in cannabidiol during his specialty training and has been following the scientific literature since that time.  More recently, Dr. Shaw has focused his efforts on patient-based clinical research to evaluate the use of high dose cannabidiol treatment for various medical conditions, including addiction, anxiety, autoimmune disease, cancer, pain, and sleep disorders. Based on the success of this research, he co-founded the cannabinoid therapeutics company REBEL MD, with the mission of developing pharmaceutical-grade treatment options for clinical endocannabinoid deficiency.